Oreola Donini, Ph.D., has been appointed vice president of Preclinical R&D at Soligenix, Inc. Dr. Donini has more than 13 years experience in drug discovery and preclinical development with start-up biotechnology companies. Dr. Donini previously worked with ESSA Pharma Inc., Inimex Pharmaceuticals Inc. and Kinetek Pharmaceuticals Inc., developing novel therapies for infectious disease, cancer, and supportive care.     Dr. Donini is a co-inventor and leader of the SGX94 innate defense regulat...